Fresenius SE KGaA's (ETR:FRE) stock is up by a considerable 16% over the past three months. However, we decided to ...

Fresenius SE's restructuring and dividend reinstatement signal strong growth. Read why FSNUF stock may not be a long-term buy ...

Fresenius Medical Care (FME), the world's leading provider of products and services for individuals with renal diseases, released its 2024 Annual Report including its Sustainability Statement. By ...

Kepler Capital analyst Oliver Reinberg maintained a Buy rating on Fresenius SE & Co. KGaA (0OO9 – Research Report) on March 13 and set a ...

Kepler Capital analyst Oliver Reinberg maintained a Hold rating on Fresenius Medical Care AG & Co. KGaA (0H9X – Research Report) on March ...

The US Supreme Court on Monday declined to review a Fresenius Kabi USA LLC scientist’s claim that she faced discrimination ...

The banker added: “Volatility will be higher for longer, and that can only help in the convertible space. The higher the ...

Pacira BioSciences, Inc.'s stock is up 33%, backed by a new Exparel patent, growth strategies, and market trends. Click here ...

On March 7, 2025, the District Court for the District of New Jersey entered a Stipulation and Order of Dismissal Without Prejudice in view of ...

Medical device recalls are essential to patient safety, addressing critical issues in devices that may pose health risks. Here are some of the latest recalls reported to the FDA: ...

Machine learning is driving efforts to classify MS into distinct subtypes that may predict disease course, but two experts debate whether this will advance patient care.